pharmaceutical company
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2025 | CONSTITUTION PARTNERS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination |
— | |
| 2025 | CONSTITUTION PARTNERS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2025 | CONSTITUTION PARTNERS |
2nd Quarter (Apr 1 - June 30) AMENDED |
— | |
| 2025 | CONSTITUTION PARTNERS |
2nd Quarter (Apr 1 - June 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| CONSTITUTION PARTNERS | 4 | — |
| Issue | Activities |
|---|---|
| Health Issues | 2 |
| Medical/Disease Research/Clinical Labs | 2 |